drugset

drugset / Trial / NCT02563860

Pharmacological Treatment of Rett Syndrome With Statins

NCT02563860 ↗

Phase 2 Completed 20 enrolled Montefiore Medical Center Rett Syndrome Research Trust · collab

NaSingle-groupOpen-labelTreatment

Summary

This is a phase 2 , open label, dose escalating study of Lovastatin in Rett syndrome.

Timeline

Start: 2015-07
Primary completion: 2016-07
Completion: 2016-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lovastatin	Small molecule	40 mg	—

Indications